These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 901737)

  • 41. Effects of physical training on glucose tolerance and insulin response in diabetics.
    Fujii S; Okuno Y; Okada K; Tanaka S; Seki J; Wada M; Iseki T
    Osaka City Med J; 1982; 28(1):1-8. PubMed ID: 6763179
    [No Abstract]   [Full Text] [Related]  

  • 42. [The influence of clofibrate on elevated serum lactate levels in diabetic patients treated with biguanides (author's transl)].
    Vogelberg KH; Cicmir I; Heggen ME
    Arzneimittelforschung; 1980; 30(4):683-5. PubMed ID: 7190412
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in glucose tolerance and plasma insulin during lipid-lowering treatment with diet, clofibrate and niceritrol.
    Lithell H; Vessby B; Hellsing K
    Atherosclerosis; 1982 Jun; 43(2-3):177-84. PubMed ID: 7052096
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insulin and corticoid response to intravenous fructose in relation to glucose tolerance.
    Aitken JM; Dunnigan MG
    Br Med J; 1969 Aug; 3(5665):276-7. PubMed ID: 5800368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Failure of pyridoxine to improve glucose tolerance in diabetics.
    Rao RH; Vigg BL; Rao KS
    J Clin Endocrinol Metab; 1980 Jan; 50(1):198-200. PubMed ID: 7188614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of oral clofibrate administration on intestinal 3-O-methyl glucose absorption in rat and chick.
    Raheja KL; Tepperman J; Tepperman HM
    Gen Pharmacol; 1978; 9(2):113-8. PubMed ID: 207618
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of oral hypoglycaemic agents on glucose tolerance in pancreatic diabetes.
    Joffe BI; Jackson WP; Bank S; Vinik AI
    Gut; 1972 Apr; 13(4):285-8. PubMed ID: 5033843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus.
    Kosaka K; Kuzuya T; Hagura R; Yoshinaga H
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S109-19. PubMed ID: 8894494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increase of insulin concentration in maturity-onset diabetics by phentolamine (Regitine) infusion.
    Linde J; Deckert T
    Horm Metab Res; 1973 Nov; 5(6):391-5. PubMed ID: 4766993
    [No Abstract]   [Full Text] [Related]  

  • 51. [Plasma levels of triglycerides, cholesterol, non-esterified fatty acids and uric acid, during oral glucose load, in subjects with type II diabetes and diminished glucose tolerance].
    Sinagra D; Botta RM; Lo Curzio E; Cerasola GA
    Boll Soc Ital Biol Sper; 1982 Aug; 58(15):964-70. PubMed ID: 6751356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of clofibrate with halofenate in diabetics with hyperlipidaemia.
    Krut LH; Seftel HC; Joffe BI
    S Afr Med J; 1977 Mar; 51(11):348-52. PubMed ID: 323994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clofibrate and carbohydrate metabolism: behavior of blood insulin in patients with blood lipid disorders].
    Ceruso D; Frisina N; Nicita-Mauro V
    Boll Soc Ital Cardiol; 1975; 20(11):1439-47. PubMed ID: 1234442
    [No Abstract]   [Full Text] [Related]  

  • 54. Lipid, glucose, and insulin interrelationships in normal, prediabetic, and chemical diabetic subjects.
    Kyner JL; Levy RI; Soeldner JS; Gleason RE; Fredrickson DS
    J Lab Clin Med; 1976 Sep; 88(3):345-58. PubMed ID: 956689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The diabetogenic action of somatostatin in healthy subjects and in maturity onset diabetics.
    Waldhäusl W; Bratusch-Marrain P; Dudczak R; Deutsch E
    J Clin Endocrinol Metab; 1977 May; 44(5):876-83. PubMed ID: 870515
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effects of treatment with clofibrate on insulin response to venous overload with glucose].
    Carapezzi C; Palummeri E; Ceccato S; Soncini G; Passeri M
    G Clin Med; 1976; 57(7-8):265-78. PubMed ID: 1022600
    [No Abstract]   [Full Text] [Related]  

  • 57. [Influence of obesity and maturity-onset diabetes on the kinetics of NEFA during oral glucose tolerance tests (OGTT)].
    Pasquali R; Parenti M; Della Rocca E; Rago S; Bianchi V; Gallo C; Calliva R; Melchionda N
    G Clin Med; 1979 Jul; 60(7):549-59. PubMed ID: 398303
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of a high-carbohydrate diet on blood glucose, insulin and triglyceride levels in normal and obese subjects and in obese subjects with impaired glucose tolerance.
    Silva ME; Pupo AA; Ursich MJ
    Braz J Med Biol Res; 1987; 20(3-4):339-50. PubMed ID: 3330460
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Growth hormone response to arginine in normal subjects and in patients with chemical diabetes and effect of clofibrate and of metergoline.
    Pontiroli AE; Viberti G; Pozza G
    Proc Soc Exp Biol Med; 1977 Jun; 155(2):160-3. PubMed ID: 866345
    [No Abstract]   [Full Text] [Related]  

  • 60. Carbohydrate tolerance, plasma insulin, growth hormone and lipid levels in Indian and Black diabetics.
    Asmal AC; Leary WP
    S Afr Med J; 1975 May; 49(20):810-2. PubMed ID: 1154133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.